SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing intense market volatility as investors await quarterly financial reports and potential updates on key corporate initiatives. The conversation among community members remains sharply polarized, blending heated political discourse with speculation over the stock's future performance following recent fluctuations.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trading amidst significant volatility as the market reacts to reports of renewed attacks on energy infrastructure in the Middle East, sparking intense community debate over supply risks versus geopolitical posturing. Traders are closely monitoring the impact of regional hostilities on tanker routes and energy supplies while grappling with conflicting signals regarding potential diplomatic interventions.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors weigh an upcoming EMA decision on its flagship drug Yartemlea against its potential as a key acquisition target, following recent insider confidence signaled by debt buybacks and a positive U.S. commercial outlook. The community is actively discussing potential short squeezes, interpreting the recent volatility as institutional accumulation ahead of major catalyst dates.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is experiencing significant volatility as the market balances strong fundamental growth and surging global LNG spot prices against recurring geopolitical tensions in the Middle East. While community members highlight the stock's potential as a major U.S. LNG exporter, trading remains heavily influenced by speculative news cycles regarding conflict in the Strait of Hormuz and diplomatic rhetoric.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending as investors react to the EU approval of oral Wegovy and ongoing prescription momentum that outpaces competitor offerings. Community sentiment is largely focused on the company's valuation relative to its long-term potential, with many discussing the stock as an undervalued opportunity ahead of upcoming earnings despite recent pipeline setbacks.

J.P. Morgan Exchange-Traded Fund Trust - JPMorgan Nasdaq Equity Premium Income ETF

JPMorgan Nasdaq Equity Premium Income ETF

JEPQ is trending as investors focus on its monthly dividend consistency and its role in income-focused portfolios, with the community actively discussing dividend payouts, ex-dividend dates, and strategies for reinvesting distributions during market volatility. Shareholders are debating the trade-offs between JEPQ's tech-heavy growth exposure and other income ETFs, while many look toward long-term accumulation to build reliable monthly cash flow.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Precigen is experiencing significant volatility and downward pressure as investors closely monitor competitive dynamics with Inovio and digest recent insider trading activity. Community sentiment remains deeply divided, with many long-term shareholders expressing frustration over price action while aggressively defending the stocks fundamentals and the commercial potential of their Papzimeos platform ahead of upcoming earnings.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors debate the impact of newly announced federal government initiatives designed to accelerate the deployment of advanced nuclear reactors for AI data centers. While some community members remain skeptical regarding the company's path to profitability and missing previous milestones, others see the federal support and growing power demand as a significant catalyst for a long-term turnaround.

Themes ETF Trust - Leverage Shares 2X Short SPCX Daily ETF

Leverage Shares 2x Short SPCX Daily ETF 

SSPC is currently a focal point for traders looking to hedge against or speculate on SpaceX's volatility, particularly with upcoming lockup expirations and valuation concerns driving intense short-interest. The community remains deeply divided, with aggressive day traders actively flipping between the leveraged bear ETF and its bullish counterpart, $SPCH, as they closely monitor the underlying stock's price action.

Trulieve Cannabis Corp. engages in the cultivation, processing, manufacturing, and retail distribution of medical and adult-use cannabis products. It cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. The company was founded by Kim Rivers & Jason Pernell on September 17, 1940 and is headquartered in Tallahassee, FL.

Trulieve Cannabis Corp - Ordinary Shares (Sub Voting)

Trulieve Cannabis Corp 

Trulieve Cannabis Corp is currently trending as the cannabis sector braces for the conclusion of DEA administrative hearings, with investors actively discussing potential federal rescheduling and the company's expansion into DEA-registered medical pharmacies. Sentiment remains divided as the community debates whether the stock is undergoing an accumulation phase ahead of anticipated growth or remains vulnerable to broader market volatility and short-selling pressure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Citius Oncology, Inc. is a biopharmaceutical company, which engages in developing and commercializing targeted oncology therapies. Its lead product candidate is LYMPHIR, an engineered IL-2 diphtheria toxin fusion protein, for the treatment of patients with persistent or recurrent CTCL, a rare form of non-Hodgkin lymphoma. The company was founded on March 1, 2021 and is headquartered in Cranford, NJ.

Citius Oncology Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.5923
Prev Close	$0.5738
Open	$0.598
Dividend Yield	0.00%
50-Day Moving Average	$0.6992
Beta	-2.13
Avg. Volume	60,543.50
PE Ratio	-1.23

52-Week High	$2.31
52-Week Low	$0.4912
Market Capitalization	$53.35M
EPS (Annual)	-$0.338
Price to Book	1.51
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info